EATG » Projects » European Patients’ Academy on Therapeutic Innovation – EUPATI

European Patients’ Academy on Therapeutic Innovation – EUPATI

eupati_logo_trans_po

EUPATI is a Consortium of 29 organisations, led by the European Patients’ Forum comprising a combination of pan-European patient organisations, academic and not for profit organisations expert in patient and public engagement and EFPIA member companies.

Project aims: EUPATI 2017 Programme builds on the EUPATI project (February 2012- January 2017), which aimed at providing scientifically reliable, objective, comprehensive information to patients on medicines research and development and to increase the capacities and capabilities of well-informed patients and patient organisations to be effective advocates and advisors in medicines research, e.g.  in clinical trials, with regulatory authorities and in ethics.

Project leader: European Patients Forum (EPF)

Main partners: Steering Group includes EPF, Bayer, EATG, ISPOR, Novo-Nordisk, GSK, Eurordis, IPPOSI, Biopeople and EFGCP. The consortium (in development), includes currently about 30 different stakeholders from patient organisations, academia, regulators and industry.

Duration: February 2017 – December 2019

Main funding source/programme:  Industry, public partners and EIT in a PPP structure

Budget: Approx 500,000 EUR, 28,900 EUR for EATG

Website: http://www.eupati.eu/

Contact person(s): Giorgio Barbareschi (office) at giorgio.barbareschi@eatg.org; Maria Dutarte (office) at maria.dutarte@eatg; David Haerry (EATG membership) at david@haerry.org; Tamás Bereczky (EATG membership) at tamas.bereczky@eatg.org.

Share on FacebookTweet about this on TwitterShare on Google+Pin on PinterestShare on LinkedIn